Armistice Capital, LLC 13D and 13G filings for PDS Biotechnology Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-15 12:27 pm Purchase | 2025-06-30 | 13G | PDS Biotechnology Corporation PDSB | Armistice Capital, LLC | 2,812,000 5.670% | 2,812,000 (New Position) | Filing |
| 2025-08-14 8:52 pm Sale | 2025-06-30 | 13G | PDS Biotechnology Corporation PDSB | Armistice Capital, LLC | 2,283,288 4.990% | -2,264,637 (-49.79%) | Filing |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | PDS Biotechnology Corporation PDSB | Armistice Capital, LLC | 4,547,925 9.990% | 4,547,925 (New Position) | Filing |